https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Renal impairment associated with tenofovir disoproxil fumarate for antiretroviral therapy and HIV pre-exposure prophylaxis: An observational cohort study https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54489 Wed 28 Feb 2024 16:31:52 AEDT ]]> Structural barriers to timely initiation of antiretroviral treatment in Vietnam: findings from six outpatient clinics https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:15126 Wed 11 Apr 2018 14:45:44 AEST ]]> HIV in (and out of) the clinic: biomedicine, traditional medicine and spiritual healing in Harare https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19591 Wed 11 Apr 2018 14:03:19 AEST ]]> Community mobilisation and HIV activism in Zimbabwe https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38844 Thu 24 Feb 2022 16:12:42 AEDT ]]> Fertility, contraceptive use and client-provider discussions regarding fertility plans among women living with HIV in Western Ethiopia https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39123 Thu 14 Mar 2024 09:06:30 AEDT ]]> Governing at a distance: mainstreaming of Australian HIV/AIDS treatments and services 1989-1996 reconsidered https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:8155 Sat 24 Mar 2018 08:36:06 AEDT ]]> HIV in Harare: the role and relevance of social stigma https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19087 Sat 24 Mar 2018 08:05:23 AEDT ]]> Determinants of virological failure after 1 year's antiretroviral therapy in Vietnamese people with HIV: findings from a retrospective cohort of 13 outpatient clinics in six provinces https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18868 3 and 101–200 cells/mm3 were statistically significantly less likely to have virological failure, compared to those with a baseline CD4 count lower than 50 cells/mm 3 (OR=0.61, 95% CI 0.23–0.89; and OR=0.43, 0.18–0.78, respectively). In contrast, patients with a history of injecting drug use were statistically significantly more likely to have viraemia than otherwise (OR=1.32, 1.16–1.67). The PPV of the WHO immunological criteria was 60.1% (57.1–69.3%). Conclusions: Routine viral load tests should be conducted early to detect virological failure and prevent unnecessary changes to second-line treatments. To improve treatment outcomes, timely ART initiation and adherence to treatment among those with history of injecting drug use should be promoted.]]> Sat 24 Mar 2018 08:03:14 AEDT ]]> Cost-effectiveness of antiretroviral therapy expansion strategies in Vietnam https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:17804 Sat 24 Mar 2018 07:57:36 AEDT ]]>